PubMed Health⌕ Search

Biomedical subjects

R S Ott

Publications and source records attributed to R S Ott.

At least 37 records · Page 2Linked to original sources
PubMed1987

Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils.

Serial blood samples were collected and plasma concentrations of florfenicol (FLO) were measured following the administration of an intravenous bolus of 50 mg/kg FLO to five healthy non-lactating dairy cows. A triexponential equation provided the best fit of the data for four of the five cows. The mean value for beta corresponded to a half-life of 3.2 h. The mean apparent volume of distribution was 0.67 l/kg, and the mean body clearance was 0.15 l/kg/h. The extent of binding of FLO to bovine plasma proteins was determined in vitro at concentrations of 5 micrograms/ml and 50 micrograms/ml by equilibrium dialysis and ultrafiltration. The drug was 18% and 19% bound by equilibrium dialysis, and 23% and 19% bound by ultrafiltration, at 5 micrograms/ml and 50 micrograms/ml, respectively. Phagocytosis of 32phosphorus-labelled Staphylococcus aureus by bovine blood neutrophils was compared in vitro between neutrophils incubated in phosphate-buffered saline alone or in combination with 5, 125, or 1000 micrograms/ml chloramphenicol or FLO. There was no significant effect of chloramphenicol at any concentration. Florfenicol significantly inhibited phagocytosis at all concentrations, but the percentage inhibition was small. The clinical significance, if any, of this effect of FLO remains to be demonstrated.

Animals↗
PubMed1987

Effects of zeranol on reproduction in beef bulls: luteinizing hormone, follicle-stimulating hormone, and testosterone secretion in response to gonadotropin-releasing hormone and human chorionic gonadotropin.

Effects of zeranol on the maturation of the adenohypophyseal-gonadal axis were studied in beef bulls. Calves were implanted with 36 mg of zeranol at 3-month intervals from birth through 6 months of age (group 2, n = 10) or were not treated (control group 1, n = 10). After 9 months, group-2 calves were given implants of 36 mg of zeranol at 3-month intervals through 18 months of age (group 2B, n = 5) or were not reimplanted (group 2A, n = 5). Areas under the curves outlined by concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone for 6 hours after the administration of 100 micrograms of gonadotropin-releasing hormone (GnRH) were calculated. Gonadotropin-releasing hormone was administered at 3-month intervals from 1.5 through 19.5 months of age. Areas under the curves for concentrations of testosterone for 4 hours after the administration of 10,000 IU of human chorionic gonadotropin (HCG) at 4.5, 7.5, and 10.5 months or 1,000 IU at 13.5 and 16.5 months of age also were calculated. The amount of FSH released was greater (P less than 0.05) for group-2 than for group-1 calves at 4.5 and 7.5 months of age. The amount of FSH released in groups 2A and 2B tended (P less than 0.10) to be greater than that for group 1. Significant differences between groups 2A and 2B were not observed. The amount of LH released at 7.5 months of age was less for groups 1 and 2 than that at earlier ages, and the decrease was greater (P less than 0.05) for group 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1987

Effects of zeranol on reproduction in beef bulls: scrotal circumference, serving ability, semen characteristics, and pathologic changes of the reproductive organs.

Effects of zeranol on scrotal circumference, serving ability, semen characteristics, and postmortem measurements of the genital organs were determined in beef bulls from 9 to 20 months of age. Group 1 (n = 5) served as a nonimplanted control group. Group 2A (n = 5) was implanted with 36 mg of zeranol at birth and at 3 and 6 months of age. Group 2B (n = 5) was implanted with 36 mg of zeranol every 3 months from birth through 18 months of age. Scrotal circumference was adversely affected by zeranol in groups 2A and 2B, but values approached those of group 1 with increasing age. Serving ability was also affected adversely but tended to recover with increasing age. Semen quality was low in groups 2A and 2B and did not improve with increasing age. There was no difference in testicular weight, vesicular gland weight, and penis length among groups when bulls were slaughtered at 20 months of age. Epididymal weight was greater in group-2B bulls and was most likely a consequence of epididymal lesions. Histologic examination of the genital organs revealed that zeranol induced adenomyosis and sperm granulomas in the caudae epididymidis and markedly altered the structure of the sexual accessory glands of bulls in groups 2A and 2B. Alterations in the vesicular glands were characterized by reduced alveolar development and an increase in connective tissue. Low epithelium associated with focal areas of squamous metaplasia were common in the prostate of groups 2A and 2B bulls. Lesions in the bulbourethral glands were characterized by low glandular epithelium, focal areas of squamous metaplasia, cystic collecting ducts, and an increase in connective tissue. Groups 2A and 2B had more abnormal seminiferous tubules than did group 1. Lesions in groups 2A and 2B may have been direct effects of zeranol or may have resulted from reduced testosterone secretion.

Animals↗
PubMed1987

Changes in basal lamina of seminiferous tubules associated with deranged spermatogenesis in the bull.

The basal lamina of seminiferous tubules of 16 beef bulls, with scrotal circumferences (SC) from 40.5 to 28 cm, was characterized. The mean thickness of basal laminae was from 0.55 to 0.94 micron in normospermic bulls with SC greater than 30 cm. Of 3 bulls that had a SC less than 30 cm, 1 had hypoplastic testes and was azoospermic, whereas 2 bulls had atrophic changes in their testes and were oligospermic. The latter 2 bulls had thick basal laminae, with a mean of 1.35 micron and 1.68 micron, respectively, whereas basal laminae of the bull with hypoplastic testes had a mean thickness of 0.96 micron, comparable with that of bulls with normal testes (SC, greater than 30 cm). Thickness of the basal lamina of seminiferous tubules might be a useful criterion in differentiating atrophy from hypoplasia.

Animals↗
PubMed1986

Comparison of palpable corpora lutea with serum progesterone concentrations in cows.

Serum progesterone concentrations were used to evaluate rectal palpation of corpora lutea as a method for assignment of postpartum beef cows to prostaglandin treatment and nontreatment groups. On the basis of 124 evaluations, 18% of the cows were assigned incorrectly to the treatment group and 37% of the cows were assigned incorrectly to the nontreatment group. The inability of palpators to accurately select cows with a mature corpus luteum may diminish the success of estrus synchronization regimens that use rectal palpation of corpora lutea for selection of cows for prostaglandin therapy.

Animals↗
PubMed1986

Pathophysiology of small testes in beef bulls: relationship between scrotal circumference, histopathologic features of testes and epididymides, seminal characteristics, and endocrine profiles.

Tissue sections from testes and epididymides obtained from 17 young beef bulls with scrotal circumference (SC) between 27 and 40.5 cm were studied to determine whether small testes were a manifestation of lesions or a result of less, but otherwise normal, seminiferous epithelium. The SC correlated negatively with the estimates of germinal epithelial loss and positively with seminiferous epithelial area. Four bulls with SC less than 30 cm had severe lesions in their testes. Hypoplastic tubules were characterized by Sertoli's cells only with no evidence of germinal cells. Loss of germinal cells, leaving vacuolated epithelium and atrophy, were observed in degenerated tubules. Hyperplasia of Leydig's cells was observed in the vicinity of Sertoli's cell-only tubules, resulting either from degeneration or hypoplasia, and atrophy of Leydig's cells was associated with tubules devoid of Sertoli's cells. These findings indicated that Sertoli's cells may produce a factor(s) required for maintenance and regulation of Leydig's cell function. Epididymal epithelium, especially in the head, had regressed in bulls with hypoplastic and degenerative changes in their testes. Decreased sperm concentration and motility and an increased frequency of morphologic defects were observed in the 4 bulls with testicular lesions and regressed epididymal epithelium. Blood plasma profiles of cortisol, follicle-stimulating hormone, luteinizing hormone, and testosterone were determined in the 4 bulls with SC less than 30 cm and 10 of the 13 bulls with SC greater than 30 cm. There were no statistically significant (P greater than 0.1) differences in the responses to exogenous gonadotropin-releasing hormone or base-line patterns of blood plasma follicle-stimulating hormone and luteinizing hormone between the 2 groups. However, in the bulls with SC less than 30 cm, the mean concentration of testosterone was lower, whether spontaneous (P less than 0.05) or exogenous gonadotropin-releasing hormone induced (P less than 0.1). The fact that these bulls were not deficient in gonadotropins indicated that Leydig's cell function was impaired by local factors, either the factors that caused the tubular damage or those consequent to the tubular damage.

Animals↗
PubMed1985

Absence of sexual dimorphism in the goat: Induction of luteinizing hormone discharge in the castrated male and female and in the intersex with estradiol benzoate.

Gonadectomized male (n = 5) and female (n = 5) and intact intersex goats (n = 2) were injected i.m. with 50 mug 17(beta)-estradiol benzoate (EB). After treatment, there was a transient 6- to 9-hr decrease in circulating levels of LH followed by a preovulatory-like discharge of LH in all goats. Release peaked at 12 to 18 hr after EB treatment. The magnitude of discharge and the time from treatment until peak of release were not influenced by the goat's sex. These findings suggested that the positive feedback effects of estrogen on LH release were not sexually differentiated in the goat. Since tonic concentrations of LH prior to EB treatment were not different among the groups, the studies also suggested that the intersex goats lacked the inhibitory gonadal influences on gonadotropin release that characterize intact animals.

Journal Article↗
PubMed1985

Effect of washing on motility and acrosome morphology of frozen-thawed goat spermatozoa.

Semen from 4 bucks was collected using an artificial vagina and was pooled and divided into 6 aliquots. Three aliquots were washed twice, 15 minutes each time, with Ringer's solution, and the fluid was removed by centrifugation at 950 X g between washes. All 6 aliquots (3 washed and 3 unwashed) were extended with skim milk-glycerol, lactose-egg yolk-glycerol, or tris (hydroxymethyl) aminomethane-citric acid-egg yolk-glycerol and were frozen in straws to -196 C. The semen was then thawed and kept at 37 C for 8 hours. Percentage of sperm motility was estimated, and the percentage of normal acrosomes (NA) was determined at 0, 2, 4, 6, and 8 hours after thawing. The experiment was repeated 7 times. The data indicated a significant positive effect (P = 0.0009) of washing on motility, but no effect (P = 0.5347) of extender. There was also a significantly higher percentage of NA in washed semen (P less than 0.0001). Sperm extended in tris aminomethane-citric acid-egg yolk-glycerol had more NA than those extended in lactose-egg yolk-glycerol. Sperm motility and acrosome morphology were depressed also in the presence of seminal plasma for the milk extender, which did not contain egg yolk. Removal of seminal plasma from goat semen was beneficial in preserving the integrity of the spermatozoa after freezing, regardless of the extender used.

Acrosome↗
PubMed1985

Prevalence of Trypanosoma theileri in cows and fetuses at slaughter.

Blood from 171 pregnant and 65 nonpregnant cows was taken at slaughter for culture and examined during the culturing period for Trypanosoma theileri once a week for 5 weeks. Of the 171 fetuses from the pregnant cows, 119 (69.6%) were greater than or equal to 4 months gestation; blood samples from these fetuses were also taken for culture. Of 236 cows (81 of 171 [47.4%] pregnant and 20 of 65 [30.8%] nonpregnant cows), 101 (42.8%) were culture positive. More of the pregnant than nonpregnant cows were culture positive (P less than 0.05). More beef cows (48.0%) than dairy cows (34.1%) were culture positive (P less than 0.025). Two of the 119 (1.7%) fetus samples were found culture positive. The percentages of positive cultures from Brucella-reactor cows, 18 of 40 (45.0%), and from non-Brucella-reactor cows, 83 of 196 (42.3%), were similar. However, both of the culture-positive fetuses were from Brucella-reactor cows.

Animals↗
PubMed1984

Effects of repetitive norgestomet treatments on pregnancy rates in cyclic and anestrous beef heifers.

Sixty-eight 12- to 14-month-old crossbred beef heifers averaging 285 kg were assigned at random to treated (n = 35) and control (n = 33) groups to evaluate the use of repetitive norgestomet treatments. Treated heifers received an ear implant containing 6 mg norgestomet on two occasions 16 days apart. Injections of 3 mg norgestomet and 5 mg estradiol valerate (EV) were given intramuscularly the same day as first implantation (Syncro-Mate-B). Implants were removed after eight days. Four bulls were then placed in each of two pastures containing half of the treated and half of the control heifers for 24 days after the time of the first implant removal. Progesterone concentrations from blood samples collected prior to the first treatment were used to determine reproductive status. The overall pregnancy rate 64 days after first implant removal for treated anestrous heifers (61%; 14 23 ) was similar (p > 0.25) to untreated (73%; 11 15 ) and treated (75%; 9 12 ) cyclic heifers, but higher (p < 0.1) than for untreated anestrous heifers (33%; 6 18 ). This treatment advantage resulted from an increased (p < 0.01) pregnancy rate after the second implant removal. In summary, repetitive norgestomet treatments enhanced pregnancy rate in anestrous heifers within a 24-day breeding season.

Journal Article↗
PubMed1983

The effect of method of GnRH administration and short-term calf removal on ovarian function and reproductive performance in postpartum suckled beef cows administered PGF(2)alpha for estrous synchronization.

The first experiment was a 2 x 2 factorial experiment with calf removal (none or short-term) and method of GnRH administration (intramuscularly in saline or subcutaneously in gelatin capsules) as main effects. The durations of the GnRH-induced LH surges were similar among groups but the LH surges were delayed in the cows that received GnRH subcutaneously in gelatin capsules. Calf removal enhanced the GnRH-induced LH release for cows administered GnRH subcutaneously in a gelatin capsule but not for cows administered GnRH intramuscularly in saline. In the second experiment, 191 postpartum suckled beef cows were administered two injections of prostaglandin F(2)alpha(PGF(2)alpha) 11 days apart. After the second PGF(2)alpha injection, the cows were assigned to a 2 x 2 factorial experiment as in Experiment 1 plus one control group. Short-term calf removal (47 h) began 28 h after the second PGF(2)alpha injection. GnRH was administered 30 h after the time of calf removal. The number of cows that ovulated following the time of the GnRH treatment, the number that had abnormal luteal phases and the first-service pregnancy rates among treatment groups within the anestrous and cyclic cows classifications were not significantly different. However, several effects were detected and are reported.

Journal Article↗
PubMed1983

Induction of luteolysis in goats with prostaglandin F2 alpha.

On day 10 of each estrous cycle, 19 cycling does were given (IM) 1 of 3 dosage levels of prostaglandin F2 alpha (PGF2 alpha) or saline solution. After injections, goats were observed twice daily for behavioral estrus, and serum concentrations of progesterone (P4) were determined from daily blood collections to measure response to treatment. Every dose of PGF2 alpha (0.0165 mg/kg of body weight, 0.0275 mg/kg, and 0.0385 mg/kg) was administered during 20 estrous cycles, and 0.25 ml of saline solution was administered during 12 estrous cycles. Fourteen of 20, 15 of 20, 20 of 20, and 0 of 12 does exhibited signs of behavioral estrus within 96 hours of injections of 0.0165 mg of PGF2 alpha/kg, 0.0275 mg of PGF2 alpha/kg, 0.0385 mg of PGF2 alpha/kg, and saline solution, respectively. A decline in mean concentrations of peripheral P4 from 3.6, 3.8, 4.4, and 4.3 ng/ml to less than 1 ng/ml within 24 hours was observed in 15 of 20, 16 of 20, 20 of 20, and 0 of 10 does after injections of 0.0165 mg of PGF2 alpha/kg, 0.0275 mg of PGF2 alpha/kg, 0.0385 mg of PGF2 alpha/kg, and saline solution, respectively. The dosage level of 0.0385 mg of PGF2 alpha/kg (1.75 mg of PGF2 alpha/45.36 kg) was effective for induction of estrus in 100% of the does.

Animals↗
PubMed1983

Distribution of oxytetracycline in the healthy and diseased postpartum genital tract of cows.

Previously determined pharmacokinetic parameters of the disposition of oxytetracycline (OTC) in cows were used to predict an IV priming dose and a rate of constant IV infusion of OTC sufficient to approach steady-state equilibrium of the drug between plasma and genital tissue concentrations in healthy postpartum cows and postpartum cows with endometritis. After 8 hours' constant IV infusion at rates calculated to maintain a plasma concentration of approximately 5 micrograms/ml, the mean concentrations of OTC in plasma (microgram/ml) and tissues (microgram/g) of healthy and infected postpartum cows, respectively, were: plasma, 4.95 and 5.23; uterine tissue, 3.65 and 4.18; and ovarian tissue, 4.57 and 4.53. The mean plasma to genital tissue ratios for healthy and infected postpartum cows, respectively, were 1.38 and 1.31 for uterine tissue and 1.09 and 1.16 for ovarian tissue. There were no significant differences (P greater than 0.28) between healthy and infected postpartum cows in any of the parameters investigated. However, plasma-to-genital tissue ratios of concentrations of OTC in postpartum cows as a group were significantly higher (P less than or equal to 0.03) than those previously determined in cycling cows. Computer-simulated uterine tissue concentrations of OTC, after twice daily IV doses of 11 mg of OTC/kg of body weight, indicated that this dosage regimen would provide postpartum uterine tissue concentrations greater than 5 micrograms/g during most of the dosage interval.

Animals↗
PubMed1983

Distribution of oxytetracycline in genital tract tissues of postpartum cows given the drug by intravenous and intrauterine routes.

Oxytetracycline (OTC) was administered by constant IV infusion to 3 healthy postpartum cows at rates predicted to approach a steady-state plasma concentration of 5 micrograms/ml. After 8 hours of constant IV infusion, genital tissues were surgically removed. The mean plasma-to-tissue ratios of concentrations of OTC were 0.95, 1.33, 1.88, and 1.04 (2 cows only) for caruncles, endometrium, uterine wall, and ovaries, respectively. Differences between the ratios of any 2 of the uterine tissues were statistically significant (P less than 0.05). Intrauterine (IU) infusions of 5.5 mg of OTC/kg were administered to 3 healthy postpartum cows and 3 postpartum cows with metritis. The mean values of the fraction of the drug absorbed from the uteri of cows given IU infusions of OTC were 0.50 and 0.23 for healthy postpartum cows and postpartum cows with metritis, respectively. Concentrations of OTC were high in the caruncles and endometrium of all cows at 24 hours after IU infusions of the drug. Concentrations in the plasma, uterine wall, and ovaries were low, with mean concentrations of OTC in these tissues in postpartum cows with metritis being lower than those in the same tissues of healthy postpartum cows. Computer-simulated genital tissue concentrations of OTC after twice daily IV doses of 11 mg/kg indicated that this dosage regimen would provide postpartum uterine tissue concentrations greater than 5 micrograms/g throughout the dosage interval in all tissues, except the uterine wall.

Absorption↗
PubMed1982

The effect of short term calf removal in combination with GnRH treatment and the effect of limited nursing on reproductive performance of postpartum suckled beef cows administered PGF2alpha for ovulation control.

Over a two year period, postpartum suckled Hereford and Angus Cows (n=213) were administered two injections of PGF2alpha (25 mg/injection) and divided into three groups. No additional treatments were administered to cows in Group I and calves were allowed to nurse their dams ad libitum. In Group II, calves were removed for 48 hours beginning on the third day following the initial PGF2alpha injection. These cows were given a subcutaneous injection of 250 microg GnRH dissolved in 2% carboxymethylcellulose midway through the 48 hour period. In Group III, calves were allowed to nurse their dams for only one hour per day for the first 7 days after the initial PGF2alpha injection. In year 1, PGF2alpha was administered 14 days apart whereas in year 2, PGF2alpha was administered 11 days apart. Cows were artificially inseminated at 72 and 96 hours after the second injection of PGF2alpha. In year 1, the numbers of cows that conceived to the timed inseminations were similar (P>.10) for the three groups. In year 2, a higher percentage of cows in groups II (P<.10) and III (P<.05) conceived to the timed inseminations than in group I. Other reproductive performance parameters were similar (P>.10) between groups for both years 1 and 2. In summary, limited nursing and short term calf removal in conjunction with GnRH treatment may improve the pregnancy rate in cows administered PGF2alpha for ovulation control.

Journal Article↗
PubMed1982

Incidence and treatments of postpartum reproductive problems in a dairy herd.

Incidence of assisted births, retained fetal membranes (RFM), and metritis were recorded in one hundred dairy cows from parturition through 14 days post-calving. Manual removal of RFM was not attempted. All RFM were excised inside the vulva and observations of natural RFM expulsion were recorded. Fifteen of 100 cows (15%) had assisted births, 27 (27%) had RFM, 8 (8%) had primary metritis not associated with other postpartum reproductive problems, and 26 (26%) had secondary metritis. Uterine swabs for culture were collected during the study from cows with postpartum reproductive problems. E . coli was the most common organism isolated (69.4%). Sensitivities of all isolates to penicillin, tetracycline, and triple sulfa were 44.0%, 59.5%, and 36.9% respectively. One of two antibiotic treatments were administered to cows with these postpartum reproductive problems. Treated animals received either 5 g. tetracycline powder IU on day 1 of treatment plus 10.5 million units procaine penicillin G IM on days 1, 2, and 3; or 4 Sulfaurea boluses IU on day 1. Despite the antibiotic treatments, 26 of 34 cows having either assisted birth and/or RFM developed metritis (76%). Neither treatment regimen was superior to the other. The poor results of antimicrobial therapy suggested the futility of routine administration of therapeutic agents for postpartum reproductive problems. Treatment failure was attributed to ineffective drugs or inadequate dosage regimens.

Journal Article↗
PubMed1982

Distribution of oxytetracycline in the genital tract of cows.

Pharmacokinetic parameters of the disposition of oxytetracycline (OTC) were investigated in healthy cycling dairy cows after a single IV dose of 22 mg/kg of body weight. The biological half-life of OTC was 6.5 hours. These data were used to predict an IV priming dose and a rate of constant IV infusion of OTC sufficient to approach steady-state equilibrium of the drug between a plasma concentration of approximately 5 microgram/ml and a uterine tissue concentration. After 8 hours' constant IV infusion, the mean plasma concentration of OTC was 4.86 +/- 0.68 microgram/ml and the mean uterine tissue concentration of OTC was 4.50 +/- 0.45 microgram/ml. The mean ratio of plasma-to-uterine tissue OTC concentrations was 1.08. Computer-stimulated IV multiple doses of OTC at 11 mg/kg every 12 hours and 11 mg/kg every 24 hours suggested that the former dosage regimen could provide uterine tissue concentrations greater than 5 microgram/ml during the dosage interval, whereas the latter could provide such concentrations for only the first 12 hours of a 24-hour dosage interval.

Animals↗